Keyphrases
Thyroid Cancer
69%
Proteostasis
63%
High-throughput Screening
52%
Non-canonical Pathway
50%
Radioiodide
50%
Radioiodide Uptake
50%
Iodide Uptake
48%
Yellow Fluorescent Protein
45%
Human Sodium Iodide Symporter (hNIS)
42%
Radioiodine Therapy
38%
Drug Repurposing
38%
Proteostasis Network
36%
Radioiodine Uptake
36%
Drug Strategy
33%
Iodide
33%
Combinatorial Approach
33%
Combinatorial Drugs
31%
Autophagy
28%
Thyroid Cancer Cells
25%
Cell-based
22%
Cellular Programming
22%
Proteasomal Degradation
22%
Dysregulation
20%
Fold Increase
20%
Intracellular Processing
20%
Ablation
20%
Thyroid Cells
17%
Human Tumors
16%
Recurrence Prediction
16%
Oncogenic Pathways
16%
Symporter
16%
Risk Score
16%
Molecular Processes
16%
Rigorous Evaluation
16%
Cancer Cells
16%
Screening Approach
16%
Autophagy Modulators
16%
High-throughput
16%
Vorinostat
16%
Predictive Marker
16%
Papillary Thyroid Cancer
15%
Recurrent Disease
13%
Ablating
13%
Secondary Screening
11%
EC50
11%
Drug Dosing
11%
125I
11%
Clotrimazole
11%
Endoplasmic Reticulum-associated Degradation
8%
Protein Homeostasis
8%
Medicine and Dentistry
Thyroid Cancer
76%
Radioactive Iodine
73%
Protein Homeostasis
47%
Yellow Fluorescent Protein
40%
High Throughput Screening
37%
Drug Repositioning
33%
Recurrent Disease
29%
Cancer Cell
25%
Thyroid Cell
25%
Autophagy
23%
Vorinostat
20%
Radioiodine Therapy
16%
Predictive Marker
16%
Sodium Iodide Symporter
14%
Clotrimazole
11%
Iodine 125
9%
Papillary Thyroid Cancer
9%
Endoplasmic Reticulum Associated Degradation
7%
Metastatic Carcinoma
5%
Ebastine
5%
Histone Deacetylase Inhibitor
5%
Reverse Transcription Polymerase Chain Reaction
5%
Dimethyl Sulfoxide
5%
Messenger RNA
5%
Pharmacology, Toxicology and Pharmaceutical Science
Radioactive Iodine
100%
Thyroid Cancer
76%
Yellow Fluorescent Protein
40%
Recurrent Disease
38%
Drug Repositioning
33%
High-Throughput Screening
25%
Drug Screening
20%
Vorinostat
20%
Sodium Iodide Symporter
18%
Clotrimazole
11%
EC50
10%
Drug Dose
10%
Iodine-125
9%
Thyroid Papillary Carcinoma
9%
Ebastine
5%
Messenger RNA
5%
Dimethyl Sulfoxide
5%
Histone Deacetylase Inhibitor
5%
